News & Updates
Showing Pharmacy articles
Showing
Show Multimedia Only

Dextromethorphan-bupropion relieves symptoms in major depressive disorder
13 Jul 2022
Treatment with dextromethorphan-bupropion (AXS-05) significantly improves depressive symptoms relative to bupropion alone and is well tolerated in patients with major depression, results of a phase II trial have shown.
13 Jul 2022

Ozoralizumab shows therapeutic potential in rheumatoid arthritis
13 Jul 2022
Treatment with the next-generation anti-TNFα antibody yields marked improvements in the signs and symptoms of rheumatoid arthritis in patients with inadequate response to methotrexate (MTX), while having an acceptable safety profile, as shown in the phase II/III OHZORA trial.
13 Jul 2022

Solithromycin safe, effective in paediatric community-acquired bacterial pneumonia
12 Jul 2022
Treatment with intravenous or oral solithromycin is well-tolerated and leads to clinical improvement in most children and adolescents with community-acquired bacterial pneumonia (CABP), results of a recent study have shown.
12 Jul 2022






